​

Tarsus Pharmaceuticals Ownership | Who Owns Tarsus Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Tarsus Pharmaceuticals Ownership Summary


Tarsus Pharmaceuticals is owned by 120.44% institutional investors, 2.69% insiders. Blackrock is the largest institutional shareholder, holding 9.25% of TARS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.05% of its assets in Tarsus Pharmaceuticals shares.

TARS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTarsus Pharmaceuticals120.44%2.69%-23.14%
SectorHealthcare Stocks 129.28%12.06%-41.34%
IndustryBiotech Stocks 181.42%11.67%-93.09%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock3.27M9.25%$88.79M
Blackrock funding, inc. /de3.87M8.91%$303.94M
Deep track capital, lp3.67M8.54%$230.79M
Rtw investments, lp3.36M7.81%$211.29M
Fmr3.27M7.54%$250.40M
Paradigm biocapital advisors lp2.78M6.46%$174.70M
Cowen and company2.20M6.22%$59.72M
Vanguard group2.40M5.63%$196.48M
Janus henderson group2.24M5.24%$157.22M
Vanguard capital management1.88M4.33%$147.71M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management1.57M4.48%$98.71M
Deep track capital, lp3.67M3.36%$230.79M
Paradigm biocapital advisors lp2.78M3.27%$174.70M
Cutter capital management, lp112.50K2.55%$6.23M
Tri locum partners lp328.34K2.54%$20.67M
Ghost tree capital235.00K2.00%$6.39M
Highvista strategies90.43K1.87%$7.11M
Rtw investments, lp3.36M1.80%$211.29M
Cowen and company2.20M1.64%$59.72M
Vestal point capital, lp1.05M1.54%$66.09M

Top Buyers

HolderShares% AssetsChange
Fmr3.27M0.01%2.60M
Millennium management1.43M0.03%862.54K
Vestal point capital, lp1.05M1.54%850.00K
Blackrock3.27M0.00%614.03K
Abrdn505.59K0.05%505.59K

Top Sellers

HolderShares% AssetsChange
Macquarie group---833.44K
Driehaus capital management317.58K0.12%-608.55K
Vivo capital---565.55K
Adage capital partners gp---543.00K
Lord, abbett---479.27K

New Positions

HolderShares% AssetsChangeValue
Abrdn505.59K0.05%505.59K$39.74M
Parkman healthcare partners150.00K0.97%150.00K$9.44M
Marshall wace, llp148.55K0.01%148.55K$11.68M
Cutter capital management, lp112.50K2.55%112.50K$6.23M
Cubist systematic strategies73.95K0.02%73.95K$4.40M

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Turning point benefit group-2.00
Hughes financial services-2.00
Capital performance advisors llp-5.00
Nelson, van denburg & campbell wealth management group-5.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2026264-2.22%52,265,3239.66%1201.00%1503.45%81-7.95%
Jun 30, 20262683.08%47,623,8215.50%1101.00%1455.84%864.88%
Mar 31, 2026162-35.20%17,007,525-61.39%390.37%79-42.34%60-29.41%
Dec 31, 2025158-29.15%24,700,440-44.97%570.52%84-21.50%52-41.57%
Sep 30, 202521710.15%44,818,3855.19%1051.05%105-17.32%8580.85%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.30M3.05%6.11K
Vanguard MStar Total Stk Mkt Idx Invest1.40M2.99%98.73K
Vanguard Morn Total Stk Mkt Idx Investor1.30M2.97%6.11K
First Trust NYSE Arca Biotech ETF1.34M2.86%-
Vanguard US Total Market Shares ETF1.14M2.73%-
iShares Russell 2000 ETF1.06M2.15%-
Macquarie Small Cap Growth C478.19K1.13%-73.10K
Invesco Small Cap Value A457.84K1.09%-51.75K
Vanguard Institutional Extnd Mkt Idx Tr456.16K1.04%767.00
RTW Biotech Opportunities Ord401.31K0.96%401.31K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 13, 2026Azamian Bobak R. President/CEO and Board ChairSell$803.10K
Sep 15, 2026LINK WILLIAM J PHD-Sell$59.96K
Sep 15, 2026LINK WILLIAM J PHD-Sell$914.50K
Sep 15, 2026LINK WILLIAM J PHD-Sell$5.28K
Sep 04, 2026Azamian Bobak R. President/CEO and Board ChairSell$264.68K

Insider Transactions Trends


DateBuySell
2026 Q4--
2026 Q3-14
2026 Q2-6
2026 Q1-30
2025 Q4-9

TARS Ownership FAQ


Who Owns Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals shareholders are primarily institutional investors at 120.44%, followed by 2.69% insiders and -23.13% retail investors. The average institutional ownership in Tarsus Pharmaceuticals's industry, Biotech Stocks , is 181.42%, which Tarsus Pharmaceuticals falls below.

Who owns the most shares of Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals’s largest shareholders are Blackrock (3.27M shares, 9.25%), Blackrock funding, inc. /de (3.87M shares, 8.91%), and Deep track capital, lp (3.67M shares, 8.54%). Together, they hold 26.70% of Tarsus Pharmaceuticals’s total shares outstanding.

Does Blackrock own Tarsus Pharmaceuticals?

Yes, BlackRock owns 9.25% of Tarsus Pharmaceuticals, totaling 3.27M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 88.79M$. In the last quarter, BlackRock increased its holdings by 614.03K shares, a 23.15% change.

Who is Tarsus Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tang capital management is Tarsus Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.48% of its assets in 1.57M Tarsus Pharmaceuticals shares, valued at 98.71M$.

Who is the top mutual fund holder of Tarsus Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Tarsus Pharmaceuticals shares, with 3.05% of its total shares outstanding invested in 1.3M Tarsus Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools